Related Experiment Video
Updated: Jul 2, 2025
Development of a Benchtop Model for Evaluating the Compatibility of Wound Dressing Materials with Negative Pressure Wound Therapy Systems
Published on: May 2, 2025
Deciphering Early-Stage Molecular Mechanisms of Negative Pressure Wound Therapy in a Murine Model
Yu-Chiau Shyu1,2, Ting-Shuo Huang3,4, Hua-Sheng Chiu5
1Community Medicine Research Center, Chang Gung Memorial Hospital, Keelung Branch, Keelung 204, Taiwan.
Abstract:
Negative Pressure Wound Therapy (NPWT) is a commonly employed clinical strategy for wound healing, yet its early-stage mechanisms remain poorly understood. To address this knowledge gap and overcome the limitations of human trials, we establish an NPWT C57BL/6JNarl mouse model to investigate the molecular mechanisms involved in NPWT. In this study, we investigate the intricate molecular mechanisms through which NPWT expedites wound healing. Our focus is on NPWT's modulation of inflammatory immune responses and the concurrent orchestration of multiple signal transduction pathways, resulting in shortened coagulation time and reduced inflammation. Notably, we observe a significant rise in dickkopf-related protein 1 (DKK-1) concentration during NPWT, promoting the differentiation of Hair Follicle Stem Cells (HFSCs) into epidermal cells, expediting wound closure. Under negative pressure, macrophages express and release DKK-1 cytokines, crucial for stimulating HFSC differentiation, as validated in animal experiments and in vitro studies. Our findings illuminate the inflammatory dynamics under NPWT, revealing potential signal transduction pathways. The proposed framework, involving early hemostasis, balanced inflammation, and macrophage-mediated DKK-1 induction, provides a novel perspective on enhancing wound healing during NPWT. Furthermore, these insights lay the groundwork for future pharmacological advancements in managing extensive wounds, opening avenues for targeted therapeutic interventions in wound care.
Insights
Negative Pressure Wound Therapy (NPWT) accelerates healing by reducing inflammation and promoting cell differentiation. Macrophages release DKK-1, crucial for stimulating stem cells to close wounds faster.
Area of Science:
- Wound Healing Biology
- Regenerative Medicine
- Immunology
Background:
- Negative Pressure Wound Therapy (NPWT) is vital for wound healing but its early molecular mechanisms are unclear.
- Existing research limitations necessitate animal models for mechanistic studies.
- Understanding NPWT's impact on inflammatory responses is crucial.
Purpose of the Study:
- To elucidate the molecular mechanisms underlying NPWT-accelerated wound healing.
- To investigate NPWT's modulation of inflammatory immune responses and signal transduction pathways.
- To identify key molecular factors involved in NPWT-driven wound closure.
Main Methods:
- Establishment of an NPWT mouse model (C57BL/6JNarl).
- Analysis of molecular mechanisms, including inflammatory markers and signal transduction pathways.
- In vitro and in vivo validation of macrophage-mediated DKK-1 induction and HFSC differentiation.
Main Results:
- NPWT significantly shortened coagulation time and reduced inflammation.
- A notable increase in dickkopf-related protein 1 (DKK-1) concentration was observed under NPWT.
- Macrophages were identified as key producers of DKK-1, promoting Hair Follicle Stem Cell (HFSC) differentiation into epidermal cells.
Conclusions:
- NPWT enhances wound healing through early hemostasis, balanced inflammation, and macrophage-mediated DKK-1 induction.
- DKK-1 plays a critical role in NPWT-induced HFSC differentiation and accelerated wound closure.
- Findings provide a novel framework for understanding NPWT and suggest potential targets for pharmacological interventions in wound care.
